EMA Authorised: Ghryvelin (previously Macimorelin Aeterna Zentaris) (macimorelin acetate) — Atnahs Pharma Netherlands B.V.

View source ↗

Summary

The European Medicines Agency authorised Ghryvelin (macimorelin acetate) by Atnahs Pharma Netherlands B.V. as a new diagnostic drug for growth hormone deficienc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Ghryvelin (macimorelin acetate)

Snippet

Status: Authorised. Therapeutic area: Diagnostic Techniques, Endocrine. MAH: Atnahs Pharma Netherlands B.V.. Decision date: 12/01/2024